Gyre Therapeutics (GYRE) Non Operating Income (2016 - 2025)
Historic Non Operating Income for Gyre Therapeutics (GYRE) over the last 16 years, with Q3 2025 value amounting to $727000.0.
- Gyre Therapeutics' Non Operating Income rose 106933.33% to $727000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$945000.0, marking a year-over-year decrease of 26068.7%. This contributed to the annual value of -$1.7 million for FY2024, which is 928.85% down from last year.
- As of Q3 2025, Gyre Therapeutics' Non Operating Income stood at $727000.0, which was up 106933.33% from -$145000.0 recorded in Q2 2025.
- In the past 5 years, Gyre Therapeutics' Non Operating Income ranged from a high of $727000.0 in Q3 2025 and a low of -$1.6 million during Q4 2024
- Over the past 5 years, Gyre Therapeutics' median Non Operating Income value was -$17000.0 (recorded in 2021), while the average stood at -$117058.8.
- Within the past 5 years, the most significant YoY rise in Gyre Therapeutics' Non Operating Income was 360000.0% (2023), while the steepest drop was 13320000.0% (2023).
- Quarter analysis of 5 years shows Gyre Therapeutics' Non Operating Income stood at -$20000.0 in 2021, then surged by 95.0% to -$1000.0 in 2022, then tumbled by 23600.0% to -$237000.0 in 2023, then tumbled by 589.45% to -$1.6 million in 2024, then surged by 144.49% to $727000.0 in 2025.
- Its last three reported values are $727000.0 in Q3 2025, -$145000.0 for Q2 2025, and $107000.0 during Q1 2025.